Coronavirus: Vaccination
To ask the Secretary of State for Health and Social Care, what assessment was made of the potential merits of including an examination of the evidence base relating to the spike protein and lipid nanoparticles used in Covid‑19 mRNA vaccines within the scope for oral evidence of the UK Covid‑19 Inquiry; and whether the Government has received any correspondence from the Inquiry on whether such issues fall within its remit.
Government answer
The UK COVID-19 Inquiry is an independent statutory inquiry. As an independent body, it is responsible for determining its own scope, lines of investigation, and the evidence it seeks. Decisions about whether to include examination of specific scientific or technical matters, such as the evidence base relating to spike proteins or lipid nanoparticles, fall within the inquiry’s discretion.
The Medicines and Healthcare products Regulatory Agency has not received any specific correspondence or instruction from the inquiry relating to spike proteins or lipid nanoparticles.